Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 9:04 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | ADAR1 Capital Management LLC | 6,994,246 9.990% | 6,994,246 (New Position) | Filing History |
| 2025-02-14 5:35 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Armistice Capital, LLC | 3,529,006 4.990% | 2,770,121 (+365.03%) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Nantahala Capital Management, LLC | 5,298,624 7.540% | 5,298,624 (New Position) | Filing History |
| 2025-02-14 4:08 pm Sale | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Point72 Asset Management, L.P. | 0 0.000% | -625,000 (Position Closed) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Fairmount Funds Management LLC | 7,018,575 9.900% | 398,264 (+6.02%) | Filing History |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | Inhibikase Therapeutics, Inc. IKT | Armistice Capital, LLC | 758,885 9.990% | 758,885 (New Position) | Filing History |
| 2024-10-28 5:26 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | SP IKT Holdings LLC | 5,840,000 8.690% | 5,840,000 (New Position) | Filing History |
| 2024-10-28 4:00 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | Soleus Private Equity Fund III, L.P. | 7,228,908 9.990% | 7,228,908 (New Position) | Filing History |
| 2024-10-25 5:50 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | Sands Capital Life Sciences Pulse Fund II. L.P. | 10,950,000 16.300% | 10,950,000 (New Position) | Filing History |
| 2024-10-22 4:15 pm Purchase | 2024-10-21 | 13G | Inhibikase Therapeutics, Inc. IKT | PERCEPTIVE ADVISORS LLC | 6,799,944 9.990% | 6,799,944 (New Position) | Filing History |
| 2024-10-17 7:00 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Fairmount Funds Management LLC | 6,620,311 9.900% | 6,620,311 (New Position) | Filing History |
| 2024-10-17 4:05 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Commodore Capital LP | 6,807,507 9.990% | 6,807,507 (New Position) | Filing History |
| 2024-10-10 4:10 pm Purchase | 2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT | Point72 Asset Management, L.P. | 625,000 8.400% | 625,000 (New Position) | Filing History |
| 2023-02-24 12:27 pm Sale | 2023-02-22 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 223,500 4.780% | -29,333 (-11.60%) | Filing History |
| 2023-02-15 7:45 pm Purchase | 2022-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Werner Milton H. | 926,485 19.680% | 16,812 (+1.85%) | Filing History |
| 2023-01-31 11:59 am Unchanged | 2023-01-25 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 4.120% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:15 pm Purchase | 2021-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Werner Milton H. | 909,673 21.700% | 2,736 (+0.30%) | Filing History |
| 2022-01-11 12:04 pm Purchase | 2022-01-10 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 6.030% | 252,833 (New Position) | Filing History |
| 2021-12-15 12:52 pm Sale | 2021-12-14 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 208,333 4.970% | -35,786 (-14.66%) | Filing History |
| 2021-06-21 12:01 pm Purchase | 2021-06-16 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 244,119 5.830% | 244,119 (New Position) | Filing History |